Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bümming

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|May 24, 2007
Reducing uncertainty in health-care resource allocationT Simonsson, K Sjölund, P Bümming, et al.
The British Journal of Surgery|May 18, 2006
Population-based study of the diagnosis and treatment of gastrointestinal stromal tumoursP Bümming, H Ahlman, J Andersson, et al.
BJS Open|October 23, 2021
Incidence, detection and outcome of differentiated thyroid cancer in Western SwedenJ Dahlberg, C Adok, P Bümming, et al.
British Journal of Cancer|May 30, 2007
Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)B Nilsson, K Sjölund, L-G Kindblom, et al.
British Journal of Cancer|July 31, 2003
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patientsP Bümming, J Andersson, J M Meis-Kindblom, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|May 24, 2007
Reducing uncertainty in health-care resource allocationT Simonsson, K Sjölund, P Bümming, et al.
The British Journal of Surgery|May 18, 2006
Population-based study of the diagnosis and treatment of gastrointestinal stromal tumoursP Bümming, H Ahlman, J Andersson, et al.
BJS Open|October 23, 2021
Incidence, detection and outcome of differentiated thyroid cancer in Western SwedenJ Dahlberg, C Adok, P Bümming, et al.
British Journal of Cancer|May 30, 2007
Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)B Nilsson, K Sjölund, L-G Kindblom, et al.
British Journal of Cancer|July 31, 2003
Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patientsP Bümming, J Andersson, J M Meis-Kindblom, et al.
Pageof 1